Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine

Journal of Clinical Virology

Volumn 19, Issue 1-2, 2000, Pages 43-56

  Halpern, Aaron L ^a,b,c  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c CELERA GENOMICS   (United States)

Author keywords

Cross protection; Host linked evolution; Mutation rate; Population bottleneck; Selection; Vaccine escape; Zoonosis

Indexed keywords

PAPILLOMAVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; COMPARATIVE STUDY; EVOLUTION; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; VACCINATION; VIRION; WART VIRUS;

ANIMALS; EVOLUTION; HIV; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYLOGENY; TUMOR VIRUS INFECTIONS; VARIATION (GENETICS); VIRAL VACCINES;

EID: 0033736817     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(00)00127-X     Document Type: Article

References (63)

1. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients
2. Evolution of papillomaviruses
3. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms
4. Animal papillomaviruses
5. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group
6. Weighted neighbor joining: A likelihood-based approach to distance-based phylogeny reconstruction
7. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind
8. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy
9. Genomic diversity and evolution of papillomaviruses in rhesus monkeys
10. Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts
11. Genital papillomaviruses (PVs) and epidermodysplasia verruciformis PVs occur in the same monkey species: Implications for PV evolution
12. Divergent human papillomavirus type 16 variants are serologically cross-reactive
13. Genetic heterogenity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: Evidence for multiple allelic forms of HPV5 and HPV8 E6 genes
14. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region
15. PHYLIP - Phylogeny inference package (version 3.2)
16. Potential strategies utilised by papillomavirus to evade host immunity
17. The mystery of humanity's missing mutations
18. Assessing recombination in HPV, part I
19. Evolutionary distances for protein-coding sequences: Modeling site-specific residue frequencies
20. A novel human papillomavirus identified in epidermodysplasia verruciformis
21. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world
22. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree
23. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations
24. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia
25. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
26. Sequence variation in the capsid protein genes of human papillomavirus type 16 and type 31
27. Group O Human Immunodeficiency Virus-1 Infections
28. Variability and phylogeny of the L1 capsid protein gene of human papillomavirus type 5: Contribution of clusters of nonsynonymous mutations and of a 30-nucleotide duplication
29. A putative human papillomavirus type 57 new subtype isolated from plantar epidermoid cysts without intracytoplasmic inclusion bodies
30. A molecular timescale for vertebrate evolution
31. Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11
32. HIV heterogeneity and disease progression in AIDS: A model of continuous virus adaptation
33. Heterogeneity of papillomaviruses
34. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene
35. Evolution of human papillomavirus type 18: An ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups
36. Elucidating the population histories and transmission dynamics of papillomaviruses using phylogenetic trees
37. Sequence variation in the capsid protein genes of human papillomavirus type 16
38. The mid-depth method and HIV-1: A practical approach for testing hypotheses of viral epidemic history
39. HIV-1 nomenclature proposal
40. Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope
41. Human immunodeficiency virus type 1 molecular evolution and the measure of selection
42. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil
43. A cottontail rabbit papillomavirus strain (CRPVb) with strikingly divergent E6 and E7 oncoproteins: An insight in the evolution of papillomaviruses
44. Human papillomavirus type 16 DNA sequence
45. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients
46. Origins and evolution of AIDS viruses
47. Identification of a unique group of human papillomavirus type 16 sequence variants among clinical isolates from Barbados
48. Intratype variation in 12 human papillomavirus types: A worldwide perspective
49. Characterization of HPV57b: Transforming activity and comparative sequence analysis as probes for biological determinants associated with high-risk oncogenic viruses
50. Phylogenetic classification of human papillomaviruses: Correlation with clinical manifestations
51. A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera
52. Novel human papillomavirus (HPV) DNA sequences from recurrent cutaneous and mucosal lesions of a stoma-carrier
53. Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis
54. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection
55. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia
56. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants
57. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments
58. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective
59. The biological significance of human papillomavirus type 16 variants for the development of cervical neoplasia